Nutra Pharma Corp. (NPHC)

Nutra Pharma Corp. Reaches Settlement with SEC

Nutra Pharma Corp. has reached a bifurcated settlement with the SEC along with its CEO and a Consultant to the companyCORAL SPRINGS, Fla., March 22, 2024 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC: NPHC), (“Nutra Pharma” or the “Company”) reached a settlement with the U.S. Securities and Exchange Commission (“SEC”) earlier this week. On March 19, 2024, the United States District Court for the Eastern District of New York in SEC v. Nutra Pharma Corporation, Erik Deitsch a/k/a Rik Deitsch,